Akash Maniam
Portsmouth, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Tolerability, dose modification, and treatment compliance with adjuvant abemaciclib in high-risk early breast cancer: a UK real-world multicentre study (CONCISE).
Journal: ESMO real world data and digital oncology
Published: September 05, 2026
The Current Landscape of Artificial Intelligence in Positron Emission Tomography (PET) Imaging Across the Cancer Continuum.
Journal: Journal of clinical medicine
Published: January 13, 2026
A call to action: improving access to cardiac MRI for diagnosis of immune checkpoint inhibitor related myocarditis in low and middle income countries.
Journal: Cardio-oncology (London, England)
Published: August 09, 2025
The Role of Circulating Tumor DNA in Patients Treated with Adjuvant Immune Checkpoint Inhibitors: Clinical Reality or Distant Horizon?
Journal: Current oncology reports
Published: June 20, 2025
Results of Five Years of a Cancer Patient Navigation Training Program for Limited-Resource Settings in the Caribbean and Africa.
Journal: JCO global oncology
Published: June 04, 2025
Translating risk-based breast cancer screening to limited-resource settings.
Journal: BMC global and public health
Published: June 04, 2025
Correction to: Evaluation of a pilot cancer patient navigation program in the limited‑resource setting of Trinidad and Tobago.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: May 22, 2025
Unlocking precision: Bispecific T cell engagers and the next frontier in uro-oncology.
Journal: Critical reviews in oncology/hematology
Published: May 04, 2025
Antibody-Drug Conjugates in urothelial, prostate, and renal cell cancers: A review of current and emerging therapies.
Journal: Critical reviews in oncology/hematology
Published: March 19, 2025
Adjuvant immunotherapy for muscle-invasive urothelial carcinoma: Considerations for targeting patients.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: March 17, 2025
Investigating the Latest Evidence from Phase III Trials Supporting Treatment Options for De novo Clinically Lymph Node-Positive Hormone-Sensitive Prostate Cancer.
Journal: Current oncology reports
Published: March 08, 2025
Narrative review on immune-related adverse events (irAEs) of immune checkpoint inhibitors in the adjuvant therapy of urological cancers.
Journal: Chinese clinical oncology
Published: March 08, 2025
Last Updated: 09/26/2026